Liquid Biopsies help with Lung Cancer Diagnostics
/Illumina-Sponsored Study Finds Liquid Biopsy Complements Tissue-Based Genotyping in Lung Cancer
NEW YORK (GenomeWeb) – The Illumina-sponsored Actionable Genome Consortium reported this week that cell-free DNA-based tumor genotyping for non-small cell lung cancer patients is concordant with tissue tumor-based genotyping most of the time and could be particularly useful in cases where acquiring a tissue biopsy is not feasible.
The group, which includes researchers from Memorial Sloan Kettering Cancer Center, Dan-Farber Cancer Center, MD Anderson Cancer Center, Grail, and Illumina, published its study this week in Annals of Oncology.
